Hydrogen Sulfide Toxicology and Respiratory Effects

RoseyFields evaluates the toxicology of H2S using the following evidence base, drawn from the peer reviewed animal toxicology and human observational literature underlying EPA’s Integrated Risk Information System (IRIS) assessment for hydrogen sulfide.

1. Chemical Identity and Physicochemical Properties Relevant to Toxicity

Hydrogen sulfide (H2S; CASRN 7783-06-4) is a colorless, flammable gas with a molecular weight of 34.08 g/mol, recognizable at low airborne concentrations by its characteristic “rotten egg” odor and commonly referred to as “sewer gas.” Several physicochemical properties drive how RoseyFields characterizes its toxicity and exposure behavior:

Reactivity. H2S is a highly reactive, weakly acidic gas. It readily dissociates and oxidizes in aqueous and biological media, and reacts directly with metalloenzymes (most notably mitochondrial cytochrome c oxidase) and with hemoglobin (forming sulfhemoglobin). This high reactivity means H2S does not persist as an intact molecule in tissue; its toxicological action is dominated by direct, portal-of-entry chemical reactivity rather than by accumulation of the parent compound.

Water solubility and gas classification. H2S is classified as a Category 1 (highly water-soluble, reactive) inhaled gas under EPA’s inhalation dosimetry framework. Gases in this category are scrubbed efficiently by the moist mucosa of the upper respiratory tract, which concentrates delivered dose at the portal of entry (the nasal passages) rather than allowing substantial penetration to the deep lung or systemic circulation at lower exposure concentrations. This property is central to why the nasal olfactory epithelium is the most sensitive target tissue identified across the animal database (Brenneman et al., 2000; CIIT, 1983a; CIIT, 1983b; CIIT, 1983c).

Environmental persistence and bioaccumulation. H2S does not bioaccumulate in biological tissue and is not environmentally persistent as a parent compound; it is rapidly oxidized in air and water to sulfate and other sulfur species. Accordingly, RoseyFields’ toxicological characterization of H2S focuses on its acute reactivity and repeated-exposure effects at the site of contact, rather than on chronic body-burden or bioaccumulative mechanisms that are more typical of persistent organic or metal toxicants.

Volatility and exposure route dominance. Given its gaseous state at ambient temperature and pressure, inhalation is overwhelmingly the dominant, and for practical purposes the only, toxicologically significant human exposure route. A single subchronic oral gavage/dietary study in swine examined gastrointestinal effects of ingested H2S-generating compounds (Wetterau et al., 1964), but this remains the only substantial oral toxicity dataset for the chemical, and RoseyFields treats the oral route as a minor pathway of concern (see Sections 5 and 8).

2. Toxicokinetics: Absorption, Distribution, Metabolism, and Excretion (ADME)

Absorption. Because H2S is a reactive, highly water-soluble gas, inhaled H2S is absorbed efficiently across the moist mucosal surfaces of the upper respiratory tract, with the extrathoracic (nasal) region receiving a disproportionately high local dose relative to the lower respiratory tract at low-to-moderate airborne concentrations. This scrubbing behavior is the toxicokinetic basis for the regional gas dose ratio (RGDR) dosimetric adjustment applied in extrapolating the rat nasal-lesion NOAEL to a human-equivalent concentration, and is consistent with the portal-of-entry pattern of injury (olfactory epithelial lesions with a rostral-to-caudal severity gradient) reported by Brenneman et al. (2000).

Distribution. At exposure concentrations sufficient to saturate local mucosal scrubbing and metabolic clearance capacity, unmetabolized H2S can pass into the systemic circulation and distribute to tissues, including the central nervous system, where it is a chemical asphyxiant and inhibitor of mitochondrial respiration. The dose-dependent shift from a purely local (portal-of-entry) effect at lower concentrations to a systemic, life-threatening effect at high concentrations is reflected in the very steep exposure response relationship reported in human acute poisoning case series, where exposures in the 500-1,000 ppm range produce immediate unconsciousness and death (Allyn, 1931; Milby, 1962).

Metabolism. H2S is metabolized primarily by oxidation, chiefly in mitochondria, to thiosulfate and ultimately to sulfate, in a pathway with substantial detoxification capacity at low exposure rates. Sulfhemoglobin formation — an irreversible reaction between H2S and hemoglobin — has been documented as a dose-related hematological change in subchronically exposed rats, with significantly increased sulfhemoglobin levels reported in male Fischer 344 rats exposed to 80 ppm H2S (CIIT, 1983c). Because metabolic (oxidative) clearance capacity is finite, the toxicokinetics of H2S are markedly non linear: at low, sub-saturating exposure concentrations, the compound is efficiently detoxified with predominantly local (mucosal) effects, whereas at high concentrations the clearance pathway becomes saturated, permitting systemic distribution and acute, life-threatening CNS and cardiorespiratory toxicity.

Excretion. Consistent with its oxidative metabolism, H2S is eliminated predominantly as sulfate and related oxidized sulfur species, chiefly via the kidney, with a minor fraction eliminated unchanged via exhalation. RoseyFields notes that detailed, compound-specific quantitative ADME data (e.g., a validated physiologically based pharmacokinetic model, or human biomonitoring data linking exhaled or urinary sulfur species to exposure concentration) were not identified in the available literature underlying the IRIS assessment; this is treated as a data gap (Section 8).

Species and sex differences. The available subchronic inhalation database examined both mice and two rat strains (Sprague-Dawley and Fischer 344), and both sexes, permitting some cross-species and cross-sex comparison (CIIT, 1983a; CIIT, 1983b; CIIT, 1983c). Body-weight-gain depression at the highest tested concentration (80 ppm) was generally more pronounced in females than males across species (e.g., 30% versus 40% in high-dose male versus female mice, and 11.7% versus 20% in high-dose male versus female Sprague-Dawley rats), suggesting a modest sex difference in systemic sensitivity at high, clearance saturating exposure concentrations (CIIT, 1983a; CIIT, 1983c). However, the principal study used to derive the RfC point of departure (Brenneman et al., 2000) examined only adult male rats, so the quantitative POD itself does not directly incorporate this observed sex difference; RoseyFields flags this as a source of uncertainty (Section 8).

3. Mechanism(s) of Action

RoseyFields’ characterization of H2S mechanism of action operates at two exposure-dependent tiers, consistent with the toxicokinetic pattern described above:

Local (portal-of-entry) irritant mechanism. At the airborne concentrations relevant to repeated or chronic exposure, H2S acts as a direct-acting mucosal irritant. Repeated contact with the nasal olfactory mucosa produces cytotoxic injury to olfactory sensory neurons, with secondary basal cell hyperplasia as a regenerative/reparative response — the histopathological pattern documented by Brenneman et al. (2000) across multiple nasal cross-sectional levels, with the most rostral (first-contact) regions of the nasal passage showing effects at the lowest exposure concentrations tested. This local irritant mechanism is consistent with the observation that the olfactory epithelium — the tissue with the greatest first-pass contact with inhaled H2S — is the most sensitive target identified in the subchronic database.

Systemic mitochondrial/chemical asphyxiant mechanism. At higher, clearance-saturating exposure concentrations, H2S acts systemically as a potent, reversible inhibitor of mitochondrial cytochrome c oxidase (complex IV of the electron transport chain), functioning mechanistically similarly to cyanide as a cellular (histotoxic) asphyxiant. This mechanism accounts for the abrupt, steep exposure-response relationship documented in acute human poisoning case series, in which brief exposures at high concentrations (500-1,000 ppm) cause near-immediate loss of consciousness, cardiorespiratory collapse, and death (Allyn, 1931; Milby, 1962), as well as the persistent neurological sequelae reported in survivors of temporary unconsciousness (Wasch et al., 1989; Tvedt et al., 1991a; Tvedt et al., 1991b; Snyder et al., 1995).

Proposed neurodevelopmental mechanism. A more mechanistically uncertain pathway is suggested by findings of altered central neurotransmitter levels (Skrajny et al., 1992) and altered dendritic arborization of developing cerebellar Purkinje cells (Hannah and Roth, 1991) in perinatally exposed rat pups, at exposure concentrations similar to those producing nasal lesions in adult animals. The mechanistic link between these biochemical/morphological changes and any functional neurobehavioral deficit has not been established, and RoseyFields treats this as a “possible,” rather than confirmed, indicator of a distinct neurodevelopmental mode of action, consistent with the characterization applied in EPA’s neurotoxicity risk assessment guidelines framework.

Olfactory nerve paralysis and loss of warning properties. A toxicologically and forensically important feature of H2S’s mechanism is that high concentrations paralyze the olfactory nerve itself, eliminating the odor-based warning property that would otherwise allow avoidance of hazardous exposure. This mechanistic feature is central to RoseyFields’ position (see the companion risk assessment methodology materials) that odor-complaint data cannot be relied upon as a proxy for the absence of hazardous exposure.

4. Animal Toxicological Evidence by Organ System / Health Outcome

Respiratory / nasal (portal-of-entry). This is the best-characterized and most sensitive target organ system in the H2S animal database. Brenneman et al. (2000) exposed 10-week-old male CD rats (12/group) to 0, 10, 30, or 80 ppm H2S, 6 hr/day, 7 days/week, for 10 weeks, and identified no treatment related nasal lesions at 10 ppm, but multifocal, bilaterally symmetrical olfactory neuron loss and basal cell hyperplasia at 30 and 80 ppm, with severity ranging from mild to severe and a clear dose- and location dependent gradient across six examined nasal cross-sections. The Chemical Industry Institute of Toxicology’s parallel 90-day inhalation bioassays in B6C3F1 mice, Sprague-Dawley rats, and Fischer 344 rats (0, 10.1, 30.5, or 80 ppm, 6 hr/day, 5 days/week) corroborated nasal mucosal injury as a compound related effect, with minimal to mild inflammation of the anterior nasal mucosa in the majority of high-dose (80 ppm) mice of both sexes, though no compound-related nasal histopathology was identified in the rat strains at the concentrations tested in those particular bioassays (CIIT, 1983a; CIIT, 1983b; CIIT, 1983c).

Systemic/body-weight and feed consumption. Body-weight-gain depression was a consistent high-dose (80 ppm) finding across species in the CIIT subchronic bioassays: 30% and 40% depression in high-dose male and female mice, respectively, accompanied by significantly reduced feed consumption; 11.7% and

20% depression in high-dose male and female Sprague-Dawley rats; and 9.8% and 10.9% depression in high-dose male and female Fischer 344 rats (CIIT, 1983a; CIIT, 1983b; CIIT, 1983c).

Hematological. Sulfhemoglobin levels were significantly increased in male Fischer 344 rats exposed to 80 ppm H2S, indicating a direct chemical interaction between H2S and circulating hemoglobin at high, systemically-distributing exposure concentrations (CIIT, 1983c).

Reproductive and developmental. Dorman et al. (2000) conducted a one-generation reproductive and developmental toxicity study in Sprague-Dawley rats, exposing F0 males and females to 0, 10, 30, or 80 ppm H2S (6 hr/day, 7 days/week) for two weeks prior to breeding, throughout a two-week mating period, and (for pregnant females) throughout gestation, with dam and pup exposure resuming postnatally. No statistically significant effects were observed on mating index, fertility index, postimplantation loss, litter size, gestation length, or implant number; no significant effects on F0 male sperm production or morphology were found; and no treatment-related structural malformations, altered pup growth, or altered developmental landmark timing (pinnae detachment, surface righting, incisor eruption, negative geotaxis, vaginal patency, preputial separation, eyelid separation) were identified in offspring. Pups also showed no treatment-related effects on motor activity, acoustic startle response, passive avoidance, functional observational battery (FOB) parameters, or surface righting ability, and microscopic examination of pup nervous tissue revealed no treatment-related findings (Dorman et al., 2000). The same study noted testicular alterations in high-dose F0 males, but these were not statistically significant relative to controls and were not associated with any effect on reproductive performance.

Neurological/central nervous system (developmental). Two studies provide the principal animal evidence of a potential developmental neurological effect distinct from the acute asphyxiant mechanism. Hannah and Roth (1991) reported altered dendritic arborization of developing cerebellar Purkinje cells in rat pups exposed in utero and postnatally (through postnatal day 21) to 20 or 50 ppm (28 or 42 mg/m3) H2S, with the effect judged present at both concentrations, such that the lower concentration (20 ppm) was characterized by the study authors as a low-effect rather than a no-effect level. Skrajny et al. (1992) reported statistically significant (p<0.01) alterations in several brain neurotransmitter levels in rat pups exposed postnatally (postpartum days 7-21) to H2S, including decreased frontal-cortex norepinephrine at 20 ppm (28 mg/m3) on postnatal days 14 and 21, and increased frontal-cortex serotonin at 20 ppm on postnatal day 21, with additional neurotransmitter alterations reported at a higher tested concentration of 75 ppm (105 mg/m3). Neither study established a functional (behavioral) correlate of these biochemical/morphological changes, and the broader functional developmental battery in Dorman et al. (2000), covering an overlapping exposure range, did not identify treatment-related functional neurological deficits in pups.

Gastrointestinal. The only substantial gastrointestinal dataset for H2S is an oral pig study reporting a “diarrhetic digestive disorder” as the critical effect, with a reported NOAEL of 3.1 mg/kg-day and LOAEL of 15 mg/kg-day (Wetterau et al., 1964). This finding has not been reproduced in independent studies, and the original study was subsequently judged marginal in its characterization of both exposure and effect; RoseyFields does not treat this endpoint as a reliable basis for characterizing H2S gastrointestinal toxicity (see Section 8).

Hepatic, immune, cardiovascular (subchronic/chronic), and renal. RoseyFields did not identify dedicated subchronic or chronic animal studies specifically designed to evaluate hepatic, immune, cardiovascular, or renal endpoints as primary outcomes in the H2S database; gross and histopathological evaluation of these organs was conducted as part of the general CIIT subchronic bioassays, in which no compound-related lesions in these organ systems were identified at the concentrations tested (CIIT, 1983a; CIIT, 1983b; CIIT,

1983c), but these organ systems were not subjected to the more specialized functional or biomarker based testing applied to the respiratory and neurological endpoints. RoseyFields treats the cardiovascular and respiratory effects reported in acute human poisoning case series (see Section 7) as evidence of a systemic, high-concentration hazard that is mechanistically distinct from, and not directly informed by, the repeated-dose animal database for these organ systems.

Endocrine. No dedicated endocrine toxicity studies of H2S were identified beyond the reproductive hormone-relevant endpoints (sperm production/morphology, testicular histopathology) captured within Dorman et al. (2000), which did not identify significant treatment-related effects.

5. Animal Carcinogenicity Bioassay Findings

RoseyFields did not identify any chronic animal carcinogenicity bioassay (e.g., a 2-year rodent cancer study) of H2S in the available literature. No tumor findings, of any type or at any site, have been reported in any of the subchronic (90-day) inhalation studies identified (CIIT, 1983a; CIIT, 1983b; CIIT, 1983c; Brenneman et al., 2000), though these studies were not designed or of sufficient duration to serve as definitive carcinogenicity bioassays. Under the applicable EPA cancer risk assessment guidelines framework, the absence of any chronic bioassay or other relevant tumor data was determined to render the database inadequate for a carcinogenicity classification, and RoseyFields’ toxicological characterization of H2S accordingly does not include a quantitative or qualitative animal-based carcinogenicity finding.

6. Comparison of Animal-Derived Findings to Human Epidemiological Evidence

Acute, high-concentration exposure. The strongest concordance between the animal mechanistic data and human evidence is at high, life-threatening exposure concentrations. The systemic mitochondrial inhibition mechanism identified as the basis of acute lethality is directly corroborated by human case report literature documenting sudden unconsciousness, cardiorespiratory collapse, and death following brief exposures in the 500-1,000 ppm range (Allyn, 1931; Milby, 1962), and by case series documenting persistent neurological sequelae — including deficits in motor function, memory, vision, and hearing — in individuals who survived a period of unconsciousness (Tvedt et al., 1991a; Tvedt et al., 1991b), electrophysiological abnormalities (prolonged P-300 latency) following exposure (Wasch et al., 1989), and persistent neurological sequelae following an occupational mass-exposure fatality event (Snyder et al., 1995).

Portal-of-entry (olfactory) effects. The animal finding of dose-dependent olfactory epithelial injury (Brenneman et al., 2000) has a documented, though more limited, human epidemiological correlate: Hirsch and Zavala (1999) reported decreased, persistent olfactory function in workers with chronic occupational H2S exposure, providing some evidence that the portal-of-entry mechanism identified in rodents translates qualitatively to a comparable target tissue effect in humans. RoseyFields treats this concordance as meaningful support for the biological plausibility of the animal-derived nasal endpoint as a basis for human risk assessment, while noting that this single occupational cohort study does not itself provide a quantitative human dose-response relationship comparable to the animal data.

Chronic, lower-level exposure and neurobehavioral effects. The animal database’s developmental neurological findings (Hannah and Roth, 1991; Skrajny et al., 1992) have a more contested human parallel. A limited set of reports describes persistent neurobehavioral and mood-state symptoms in individuals with intermittent or continuous exposure to lower (“low-level”) H2S concentrations, short of acute poisoning (Kilburn and Warshaw, 1995; Kilburn, 1997; Kilburn, 1999). RoseyFields treats this literature as more equivocal than the acute-poisoning case series, for several reasons that likely explain the apparent divergence from the animal database: (a) the human “low-level” exposure literature is drawn from retrospective community or occupational cohorts in which exposure concentration and duration are difficult to reconstruct with precision, in contrast to the controlled, quantified exposure regimens used in animal bioassays; (b) confounding by co-exposure to other airborne contaminants is difficult to exclude in real-world community and occupational settings; and (c) the animal neurodevelopmental findings themselves are limited to the perinatal/developmental window and to biochemical/morphological (rather than confirmed functional) endpoints, so a direct comparison to reported neurobehavioral symptoms in exposed working-age adults involves an additional inferential step (extrapolating from developmental window findings in rodents to adult human neurobehavioral function) that the animal data do not directly address.

Divergence attributable to toxicokinetic and exposure-pattern differences. RoseyFields attributes much of the observed divergence between the clean, threshold-like animal dose-response pattern and the more variable human epidemiological picture to differences in exposure pattern (continuous, controlled laboratory exposure at fixed concentrations versus fluctuating, intermittent, and often poorly characterized real-world human exposure, including brief high-concentration excursions superimposed on a lower chronic background), together with the toxicokinetic non-linearity described in Section 2 (efficient local detoxification at low exposure rates versus systemic distribution once clearance capacity is exceeded), which makes cumulative or average exposure metrics a potentially poor predictor of peak driven human health outcomes.

7. Data Gaps and Areas of Ongoing Research

RoseyFields’ toxicological characterization of H2S identifies the following data gaps as material to the confidence of any risk assessment relying on this database:

Absence of a chronic (lifetime) bioassay. No chronic (approximately 2-year) inhalation or oral bioassay of H2S has been conducted in any species, in any strain, addressing either non-cancer chronic toxicity or carcinogenic potential. All repeated-dose animal data are subchronic (up to 10 weeks) in duration.

Absence of a multigenerational reproductive study. The reproductive/developmental database rests on a single one-generation study (Dorman et al., 2000); no two-generation reproductive study has been conducted.

Limited compound-specific ADME/PBPK data. RoseyFields did not identify a validated, compound specific physiologically based pharmacokinetic model for H2S nasal or systemic dosimetry, nor detailed quantitative human ADME or biomonitoring data linking exposure concentration to internal dose markers (e.g., blood sulfhemoglobin or urinary thiosulfate/sulfate) in a manner that would permit refinement of the animal-to-human dosimetric extrapolation beyond the default RGDR approach.

Unresolved functional significance of developmental neurological findings. The mechanistic and functional significance of the biochemical (Skrajny et al., 1992) and morphological (Hannah and Roth, 1991) developmental neurological changes identified in rat pups remains unresolved; no study has established a direct behavioral or functional correlate of these findings, and the broader functional developmental battery in Dorman et al. (2000) did not identify corresponding deficits.

Limited characterization of hepatic, immune, cardiovascular, renal, and endocrine endpoints. These organ systems have been evaluated only as part of general histopathological screening within subchronic bioassays designed principally around other endpoints, rather than through dedicated, endpoint-specific studies.

Absence of a validated human dose-response relationship for chronic, low-level exposure. The available human “low-level” chronic exposure literature (Kilburn and Warshaw, 1995; Kilburn, 1997; Kilburn, 1999) has not, in RoseyFields’ assessment, achieved the exposure characterization rigor needed to establish a quantitative human dose-response relationship independent of the animal-derived toxicity values.

Absence of carcinogenicity data. No chronic bioassay, epidemiological cancer study, or mechanistic genotoxicity dataset adequate to support a carcinogenicity classification for H2S has been identified.

Sex-specific quantitative dose-response data. Although the CIIT subchronic bioassays examined both sexes and observed a modest sex difference in systemic (body-weight) sensitivity at high exposure concentrations (CIIT, 1983a; CIIT, 1983c), the principal nasal-lesion dose-response dataset (Brenneman et al., 2000) is limited to male rats, leaving the quantitative sex-specificity of the most sensitive (portal-of entry) endpoint uncharacterized.

RoseyFields monitors the toxicological literature for new chronic bioassay data, PBPK modeling efforts, and improved human exposure-biomarker studies that would narrow these gaps, and updates this toxicology page as the underlying evidence base develops.

Bibliography